Suppression of ras oncogene-mediated transformation
- 31 December 1993
- book chapter
- Published by Springer Nature in Reviews of physiology, biochemistry and pharmacology
- Vol. 124, 29-92
- https://doi.org/10.1007/bfb0031031
Abstract
No abstract availableThis publication has 272 references indexed in Scilit:
- Reversal of ras‐induced inhibition of gap‐junctional intercellular communication, transformation, and tumorigenesis by lovastatinMolecular Carcinogenesis, 1993
- Regulation of the GTPase activity of the ras-related rap2 proteinBiochemical and Biophysical Research Communications, 1992
- Molecular cloning of a cDNA coding for neurofibromatosis type 1 protein isoform lacking the domain related to ras GTPase-activating proteinBiochemical and Biophysical Research Communications, 1992
- Molecular cloning of p21B and identification of p21 purified from bovine brain and human platelets as p21BBiochemical and Biophysical Research Communications, 1990
- A specific protein, p92, detected in flat revertants derived from NIH/3T3 transformed by human activated c-Ha-ras oncogeneExperimental Cell Research, 1990
- Permanent conversion of mouse and human cells transformed by activatedras orraf genes to apparently normal cells by treatment with the antibiotic azatyrosineMolecular Carcinogenesis, 1989
- Partial purification and characterization of thrombolamban, A 22,000 dalton cAMP-dependent protein kinase substrate in plateletsBiochemical and Biophysical Research Communications, 1987
- Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cellsCell, 1987
- Ouabain sensitivity is linked to ras-transformation in human HOS cellsBiochemical and Biophysical Research Communications, 1986
- Interaction of serum and cell spreading affects the growth of neoplastic and non‐neoplastic fibroblastsJournal of Supramolecular Structure and Cellular Biochemistry, 1981